Jinyu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinyu Bio-Technology Co Ltd with three other
companies in this sector in China:
Hualan Biological Engineering Inc
sales of 1.47 billion Chinese Renmimbi [US$214.98 million]
of which 92%
was Blood Product),
Beijing SL Pharmaceutical Co Ltd
(1.16 billion Chinese Renmimbi [US$169.10 million]
of which 98%
was Pharmaceuticals Industry), and
Staidson (Beijing) Biopharmaceuticals Co Ltd
(1.25 billion Chinese Renmimbi [US$182.47 million]
of which 100%
was Pharmaceutical manufacturing).
During the year ended December of 2015, sales at
Jinyu Bio-Technology Co Ltd were 1.25 billion Chinese Renmimbi (US$182.08 million).
increase of 17.3%
versus 2014, when the company's sales were 1.06 billion Chinese Renmimbi.
This was the third consecutive year of growth at Jinyu Bio-Technology Co Ltd.
Sales of Bio-Pharmaecutical saw an increase
18.6% in 2015, from
1.02 billion Chinese Renmimbi to 1.21 billion Chinese Renmimbi.
Not all segments of Jinyu Bio-Technology Co Ltd experienced an increase in sales in 2015:
sales of Textile Processing fell 52.9% to 1.31 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Jinyu Bio-Technology Co Ltd also experienced decreases in sales in
Rental and Property Management (down 14.1% to 21.42 million Chinese Renmimbi)
Energy Distribution (down 6.0% to 8.20 million Chinese Renmimbi)
Other (down 40.9% to 1.96 million Chinese Renmimbi)